Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling

Abstract

IMPORTANCE One-third of US residents have trouble paying their medical bills. They often turn to their physicians for help navigating health costs and insurance coverage.OBJECTIVE To determine whether physicians can accurately estimate out-of-pocket expenses when they are given all of the necessary information about a drug's price and a patient's insurance plan. DESIGN, SETTING, AND PARTICIPANTSThis national mail-in survey used a random sample of US physicians. The survey was sent to 900 outpatient physicians (300 each of primary care, gastroenterology, and rheumatology). Physicians were excluded if they were in training, worked primarily for the Veterans Administration or Indian Health Service, were retired, or reported 0% outpatient clinical effort. Analyses were performed from July to December 2020. MAIN OUTCOMES AND MEASURESIn a hypothetical vignette, a patient was prescribed a new drug costing $1000/month without insurance. A summary of her private insurance information was provided, including the plan's deductible, coinsurance rates, copays, and out-of-pocket maximum.Physicians were asked to estimate the drug's out-of-pocket cost at 4 time points between January and December, using the plan's 4 types of cost-sharing: (1) deductibles, (2) coinsurance, (3) copays, and (4) out-of-pocket maximums. Multivariate linear regression was used to assess differences in performance by specialty, adjusting for attitudes toward cost conversations, demographics, and clinical characteristics. RESULTSThe response rate was 45% (405 of 900) and 371 respondents met inclusion criteria.Among the respondents included in this study, 59% (n = 220) identified as male, 23% (n = 84) as Asian, 3% (n = 12) as Black, 6% (n = 24) as Hispanic, and 58% (n = 216) as White; 30% (n = 112) were primary care physicians, 35% (n = 128) were gastroenterologists, and 35% (n = 131) were rheumatologists; and the mean (SD) age was 49 (10) years. Overall, 52% of physicians (n = 192) accurately estimated costs before the deductible was met, 62% (n = 228) accurately used coinsurance information, 61% (n = 224) accurately used copay information, and 57% (n = 210) accurately estimated costs once the out-of-pocket maximum was met. Only 21% (n = 78) of physicians answered all 4 questions correctly. Ability to estimate out-of-pocket costs was not associated with specialty, attitudes toward cost conversations, or clinic characteristics. CONCLUSIONS AND RELEVANCEThis survey study found that many US physicians have difficulty estimating out-of-pocket costs, even when they have access to their patients' insurance plans. The mechanics involved in calculating real-time out-of-pocket costs are complex. These findings suggest that increased price transparency and simpler insurance cost-sharing mechanisms are needed to enable informed cost conversations at the point of prescribing.

Informed Decision Making for Anticoagulation Therapy for Atrial Fibrillation

“…Given the myriad insurance plans and cost-sharing arrangements, physicians simply do not know how much patients can expect to pay out of pocket for DOACs. 18 Unexpected out-of-pocket costs is the primary reason patients abandon drugs at the pharmacy. 19 Indeed, excessive costs associated with DOACs are associated with greater rates of nonadherence with drugs compared with warfarin.…”

Physician Perspectives on Implementation of Real-Time Benefit Tools: A Qualitative Study

“…1 2 3 Because the out-of-pocket price of a given medication can depend on the specific coverage decisions made by an insured patient's pharmacy benefit plan, real-time, patient-specific information on out-of-pocket prices could inform a prescriber's choice of medication. 4 5 6 Towards that end, Congress has mandated that Medicare Part D drug sponsors provide real-time benefits information to electronic health records (EHRs) and that EHRs include real-time benefit tools (RTBTs) to provide patient-specific information on out-of-pocket prices for medications prescribed to Medicare beneficiaries. 7 A key focus of these efforts is on clinician-facing RTBTs that leverage interoperable exchange between pharmacy benefit managers' information systems and prescribers' EHRs.…”

Deprescribing medications: Do out‐of‐pocket costs have a role?

“…Second, clinicians may find it difficult to consider the long-term financial tradeoffs of deprescribing, because they are rarely able to accurately estimate their patients' OOP medication costs. 17 The OOP cost of medication can change throughout the year, depending on drug pricing changes, drug formulary changes, and whether the patient has met their deductible or OOP maximum. Patients may also switch insurance plans or gain access to medication discounts over time.…”